Policy

For former employees, the stain of Theranos is hard to wash away

As Elizabeth Holmes' fraud trial begins, three former employees talk about moving on from such a public scandal, what they'll be watching in the case and why they don't regret working for Theranos for a minute.

Photo of Elizabeth Holmes walking.

Elizabeth Holmes, founder and former CEO of Theranos, is standing trial for fraud.

Photo by Yichuan Cao/NurPhoto via Getty Images

The first time Charlie realized that his time at Theranos might become a scarlet letter on his resume was in May of 2016.

It was a full seven months after reporter John Carreyrou published his first explosive exposé on the company, accusing Theranos' leaders of covering up serious accuracy issues with its widely hyped blood-test machines. Until that point, Charlie, a pseudonym for a former Theranos employee who agreed to speak with Protocol on the condition of anonymity, says he was "sipping the Kool-Aid," believing the company's CEO Elizabeth Holmes and COO Sunny Balwani when they said the Journal's accusations were bogus.

In the spring of 2016, though, Charlie saw for himself for the first time how the company's top brass was exaggerating its device's capabilities to outsiders — just like Carreyrou said they were. Charlie had just begun interviewing with other companies when the CEO of the very first startup he applied to stopped him short. "I was told by the CEO that their investors advised him not to hire anybody from Theranos, given what was going on in the media," Charlie said. "That was a wake-up call for me."

Over the last three years, Charlie and other former Theranos employees who spoke with Protocol anonymously have worked to put distance between themselves and their now infamous former employer, even as documentaries, books and podcasts have kept the company in the news. They've ducked incessant media requests for fear of a Google trail linking them to Theranos (hence the pseudonyms), fielded persistent questions from new colleagues and bosses who want to hear their war stories and rolled their eyes, but kept their mouths shut, in the face of press coverage they knew to be wrong.

The stain of Theranos has stood in the way of job opportunities, curbed former employees' appetite for risk and led them to scrutinize prospective employers almost as much as those employers have scrutinized them.

As jury selection begins Tuesday in Holmes' highly anticipated fraud trial, three former employees spoke with Protocol about what it's been like trying to move on from such a public scandal, what they'll be watching for as the case proceeds and why, despite it all, they don't regret working for Theranos for a minute. "It's the same as the Army for me," said one former employee we'll call Kevin, who is also a former U.S. Army veteran. "Even if it really sucks at certain times, you come out better for it."

'I was so desperate'

Despite the rejection he faced from that first startup, Charlie considers himself lucky in that he never actually had to be unemployed after Theranos, and did end up finding a job with a former employer who welcomed him back with open arms. Not everyone was as lucky.

When Kevin started applying to jobs in the spring of 2016, he didn't get any bites for months. One of those companies did ask him to answer for his time at Theranos, several rounds into the interview process, but he'll never know for sure whether that was a factor in their decision not to hire him. "I'd never had to look that much for a position before," Kevin said.

Things only got harder the longer employees spent at the company. Jane, who started at Theranos straight out of college and worked there for five years, said she stayed at Theranos "longer than I should have," in part because she'd never worked anywhere else and in part because she said she genuinely thought there was a way to turn the company around, a company she really thought was trying to do something good for the world. She'd started at Theranos before anyone knew Holmes' name and had watched its meteoric rise. But the swell of news stories soon became too big to ignore. "It was like: We're not actually trying to make things better," Jane said. "It sounds like we're just trying to cover up the mistakes."

Theranos logo outside office building Theranos headquartersPhoto: Andrej Sokolow/picture alliance via Getty Images

Jane spent five months searching for other jobs in health care and the tech field more broadly. Sometimes, she wouldn't even get a call back. Other times, she said she was pretty sure the companies only wanted to interview her because they were "nosy" and wanted to hear about Theranos. Eventually, she took a lower-level position in an unrelated field in tech because, she said, "I was so desperate." She lasted less than a year in that role before taking a full year off of work.

"I probably should have taken a break after Theranos, but I just didn't," Jane said. Now, she works for a giant tech company that she likes for the "security of it." "I don't want to work somewhere where the company is all about the CEO and not what the company actually does," she said.

One common thread uniting these former employees is the fact that the experience made them more risk averse in future career decisions. Kevin, who received what he said was a "generous" severance package from Theranos in the fall of 2016, found himself digging deep into the background of prospective employers. "I paid a lot more attention than I ever had before. What is the leadership saying? What is their vision for the company, and ethically, morally, how do they operate?" he said.

That's even as he tried to convince the people interviewing him that his time at Theranos might actually be an advantage. "You have to find a way to spin, if you want to call it that, the negativity into ways you problem-solved and did right by customers," he said.

Taking the job at Theranos had been "a leap" for Kevin, who moved across the country with his fiancée for the job. "I got caught up in the opportunity, for sure," he said. After that experience, and especially now that he has children, he said, "I don't think I could take a risk like that."

For Charlie, the experience made him question working in Silicon Valley altogether, with all of its moonshots and founder worship. "I sort of had this realization that I didn't want to go from startup to startup and be fully invested into these really ambitious goals, especially in the context of health care," he said.

"It's just been a rollercoaster for some of us."

All this time they were working to rebuild their careers, the news about Theranos didn't stop. There was a splashy Vanity Fair article in 2016, a formal indictment to sift through two years later. Carreyrou's book, "Bad Blood," was also released in 2018, and the next year, Alex Gibney's juicy HBO documentary "The Inventor" premiered.

For Charlie and Jane, every book, every documentary, every podcast and legal filing brought new fears that their names might soon be included — not because they thought they did anything wrong, but because they didn't want to appear in Google results. When the witness list for Holmes' trial came out last week, they scanned it first for their names and the names of their friends. "There's definitely a concern: Is my name going to be mentioned? Is so-and-so's name? There's conversations about that all the time," Charlie said. "It's just been a rollercoaster for some of us."

The desire for anonymity also brings with it the frustration of staying quiet, even in the face of coverage they thought was misleading or knew to be flat-out wrong. Charlie, Kevin and Jane all insist, for instance, that there was never any company-wide "Fuck you, Carreyrou," chant, as documented in cinematic detail by Vanity Fair. "That's definitely an example of an eye-roll moment," Kevin said of the Vanity Fair account. "I was at each town hall, and I don't ever remember there being an 'F U Carreyrou' chant at any of them." Charlie said someone did, however, dress up as Carreyrou for Halloween that year.

None of them bothered to refute the Vanity Fair story at the time, though, Charlie said, chalking it up to "the price of moving on."

Not that he wants to frame former Theranos employees as the victims. "There's been a lot of stories — and rightly so — on the impact on patients," he said. "But employees haven't had a voice. We've been somewhat handcuffed."

Still, none of the former employees who spoke with Protocol said they regretted working for Theranos. Charlie said when people ask him about his time there — and they always ask — he still tells them, "It was the highlight of my career."

If not for the deception, Jane said, "I'd still be working there. I loved it so much."

Both she and Charlie said some of their best friends in the world are people they met at Theranos, and they're still in almost daily contact through group chats of former Theranos workers. "When people suffer through trauma together that's what builds bonds," Jane said. "It was a somewhat disturbing experience, which is why we're so close."

The group chats are bound to light up as Holmes' trial begins this week, Jane said. But not everyone on those chats agrees about what the outcome should be. "Some people are sympathetic and understand she messed up, but don't want to see her in jail. Other people are like: She deserves something," Jane said, adding that she still doesn't know where she stands.

Kevin said his overwhelming feeling about the trial is sadness. "I'm not looking for a 'gotcha' moment," he said. Instead, he wants to know, "Are people going to step up and say: 'You know what? When I was there, I did something I'm not proud of.'"

Charlie's also looking for some accountability, or at least acknowledgment of what happened — the kind he said he never got. Even in the waning days of the company, he said, "There was never an acknowledgement that we fucked up."

Workplace

You need a healthy ‘debate culture’

From their first day, employees at Appian are encouraged to disagree with anyone at the company — including the CEO. Here’s how it works.

Appian co-founder and CEO Matt Calkins wants his employees to disagree with him.

Photo: Appian

Matt Calkins often hears that he’s polite, even deferential. But as CEO of Appian, he tells employees to challenge each other — especially their bosses — early and often.

“I love arguments. I love ideas clashing,” Calkins said. “I regard it as a personal compliment when someone respectfully dissents.”

Keep Reading Show less
Allison Levitsky
Allison Levitsky is a reporter at Protocol covering workplace issues in tech. She previously covered big tech companies and the tech workforce for the Silicon Valley Business Journal. Allison grew up in the Bay Area and graduated from UC Berkeley.

Some of the most astounding tech-enabled advances of the next decade, from cutting-edge medical research to urban traffic control and factory floor optimization, will be enabled by a device often smaller than a thumbnail: the memory chip.

While vast amounts of data are created, stored and processed every moment — by some estimates, 2.5 quintillion bytes daily — the insights in that code are unlocked by the memory chips that hold it and transfer it. “Memory will propel the next 10 years into the most transformative years in human history,” said Sanjay Mehrotra, president and CEO of Micron Technology.

Keep Reading Show less
James Daly
James Daly has a deep knowledge of creating brand voice identity, including understanding various audiences and targeting messaging accordingly. He enjoys commissioning, editing, writing, and business development, particularly in launching new ventures and building passionate audiences. Daly has led teams large and small to multiple awards and quantifiable success through a strategy built on teamwork, passion, fact-checking, intelligence, analytics, and audience growth while meeting budget goals and production deadlines in fast-paced environments. Daly is the Editorial Director of 2030 Media and a contributor at Wired.

Gopuff says it will make it through the fast-delivery slump

Maria Renz on her new role, the state of fast delivery and Gopuff’s goals for the coming year.

Gopuff has raised $4 billion at a $15 billion valuation.

Photo: Gopuff

The fast-delivery boom sent startups soaring during the pandemic, only for them to come crashing down in recent months. But Maria Renz said Gopuff is prepared to get through the slump.

“Gopuff is really well-positioned to weather through those challenges that we expect in the next year or so,” Renz told Protocol. “We're first party, we control elements of our mix, like price, very directly. And again, we have nine years of experience.”

Keep Reading Show less
Sarah Roach

Sarah (Sarahroach_) writes for Source Code at Protocol. She's a recent graduate of The George Washington University, where she studied journalism and criminal justice. She served for two years as editor-in-chief of GW's independent newspaper, The GW Hatchet. Sarah is based in New York, and can be reached at sroach@protocol.com

Enterprise

AT&T CTO: Challenges of the cloud transition are interpersonal

Jeremy Legg sat down with Protocol to discuss the race to 5G, the challenges of the cloud transition and nabbing tech talent.

AT&T CTO Jeremy Legg spoke with Protocol about the company's cloud transition and more.

Photo: AT&T

Jeremy Legg is two months into his role as CTO of AT&T, and he has been tasked with a big mandate: transforming the company into a software-driven business, with 5G and fiber as core growth areas.

This isn’t Legg’s first CTO gig, just his biggest one. He’s an entertainment biz guy who’s now at the center of the much bigger, albeit less glamorous, telecom business. Prior to joining AT&T in 2020, Legg was the CTO of WarnerMedia, where he was the technical architect behind HBO Max.

Keep Reading Show less
Michelle Ma

Michelle Ma (@himichellema) is a reporter at Protocol, where she writes about management, leadership and workplace issues in tech. Previously, she was a news editor of live journalism and special coverage for The Wall Street Journal. Prior to that, she worked as a staff writer at Wirecutter. She can be reached at mma@protocol.com.

Workplace

How Canva uses Canva

Design tips and tricks from the ultimate Canva pros: Canva employees themselves.

Employees use Canva to build the internal weekly “Canvazine,” product vision decks, team swag and more.

Illustration: Christopher T. Fong/Protocol

Ever wondered how the companies behind your favorite tech use their own products? We’ve told you how Spotify uses Spotify, How Slack uses Slack and how Meta uses its workplace tools. We talked to Canva employees about the creative ways they use the design tool.

The thing about Canva is that it's ridiculously easy to use. Anyone, regardless of skill level, can open up the app and produce a visually appealing presentation, infographic or video. The 10-year-old company has become synonymous with DIY design, serving as the preferred Instagram infographic app for the social justice “girlies.” Still, the app has plenty of overlooked features that Canvanauts (Canva’s word for its employees) use every day.

Keep Reading Show less
Lizzy Lawrence

Lizzy Lawrence ( @LizzyLaw_) is a reporter at Protocol, covering tools and productivity in the workplace. She's a recent graduate of the University of Michigan, where she studied sociology and international studies. She served as editor in chief of The Michigan Daily, her school's independent newspaper. She's based in D.C., and can be reached at llawrence@protocol.com.

Latest Stories
Bulletins